DE (IRON)

Reporting relationship: Director
Issuer ticker: IRON
Reported as of: 04 Oct 2021
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 09 Mar 2022, 17:13:07 UTC
Original report date: 06 Oct 2021
Prior SEC filing: 08 Jul 2021
Next SEC filing: 03 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Brian Piekos, attorney-in-fact

Key filing fact

David Charles Lubner filed Form 4/A - Amendment for Gemini Therapeutics, Inc. /DE (IRON) on 09 Mar 2022.

Key facts

This page summarizes David Charles Lubner's Form 4/A - Amendment filing for Gemini Therapeutics, Inc. /DE (IRON).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Mar 2022, 17:13.

Change

Previous filing in this sequence was filed on 08 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: 0
Change %
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 0
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 4/A amends and restates the original Form 4 filed on October 6, 2021 ("Original Form 4"). The stock option reported on the Original Form 4 was reported in error and was never granted to the Reporting Person.